FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:1811-1821 October 23, 2008 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

An association of gout with hypertension, diabetes, kidney disease, and cardiovascular disease has been observed since the late 19th century. Early investigators, such as Frederick Mahomed, Alexander Haig, and Nathan Smith Davis, hypothesized that uric acid might be a cause of hypertension or renal disease. In 1897, in his presidential address to the American Medical Association, Dr. Davis wrote, "High arterial tension in gout is due in part to uric acid or other toxic substances in the blood which increase the tonus of the [renal] arterioles."¹ Since agents that lower uric acid levels were not available earlier in Davis's career, . . . [Full Text of this Article]

Uric Acid and Cardiorenal Disease — Cause or Consequence?

Uric Acid and Cardiovascular Disease — A Reappraisal

Hyperuricemic Hypertension

Uric Acid, the Metabolic Syndrome, and Diabetes

Uric Acid and Chronic Kidney Disease

Other Cardiovascular Diseases Associated with Hyperuricemia

Caveats and Future Directions

Source Information

From Baylor College of Medicine, Houston (D.I.F.); Ewha Womans University School of Medicine, Seoul, Korea (D.-H.K.); and the University of Colorado Health Sciences Center, Denver (R.J.J.).

Address reprint requests to Dr. Feig at the Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX 77030, or at dfeig@bcm.tmc.edu.

Related Letters:

Uric Acid and Cardiovascular Risk
Leow M. K., Bueno C., Trivedi N., Parmar M. S., Oh J., Won H. Y., Kang S.-M., Hebert L. A., Rovin B., Feig D. I., Johnson R. J.
Extract | Full Text | PDF  
N Engl J Med 2009; 360:538-541, Jan 29, 2009. Correspondence

This article has been cited by other articles:

• Shimada, M., Johnson, R. J., May, W. S. Jr, Lingegowda, V., Sood, P., Nakagawa, T., Van, Q. C., Dass, B., Ejaz, A. A. (2009). A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant 0: gfp330v1-gfp330 [Full Text]  
• Hovind, P., Rossing, P., Tarnow, L., Johnson, R. J., Parving, H.-H. (2009). Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study. Diabetes 58: 1668-1671 [Abstract] [Full Text]  
• Peti-Peterdi, J., Toma, I., Sipos, A., Vargas, S. L. (2009). Multiphoton Imaging of Renal Regulatory Mechanisms. Physiology 24: 88-96 [Abstract] [Full Text]  
• Ding, K., Kullo, I. J. (2009). Genome-Wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors. Circ Cardiovasc Genet 2: 63-72 [Full Text]  
• Johnson, R. J., Perez-Pozo, S. E., Sautin, Y. Y., Manitius, J., Sanchez-Lozada, L. G., Feig, D. I., Shafiu, M., Segal, M., Glassock, R. J., Shimada, M., Roncal, C., Nakagawa, T. (2009). Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?. Endocr. Rev. 30: 96-116 [Abstract] [Full Text]  
• Leow, M. K., Bueno, C., Trivedi, N., Parmar, M. S., Oh, J., Won, H. Y., Kang, S.-M., Hebert, L. A., Rovin, B., Feig, D. I., Johnson, R. J. (2009). Uric Acid and Cardiovascular Risk. NEJM 360: 538-541 [Full Text]